Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGPhase 4INTERVENTIONAL

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Randomized Controlled Clinical Trial Comparing Treatment With Cloxacillin Versus Benzylpenicillin in Bacteraemia Caused by Penicillin-susceptible Staphylococcus Aureus (PSSA)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this study is to investigate if benzylpenicillin is a better treatment option than cloxacillin in patients with penicillin-susceptible Staphylococcus aureus bacteraemia.

Who May Be Eligible (Plain English)

Who May Qualify: Aged ≥18 with penicillin susceptible S. aureus bacteraemia (PSSA), and able to provide written willing to sign a consent form. Who Should NOT Join This Trial: - allergy to penicillin, - inability to give willing to sign a consent form, - concomitant growth of other clinically significant bacteria in blood cultures - neutropenia -≥ 96h with prior antibiotics - When the per oral follow up medication can not be flukloxacillin or penicillinV/Amoxicillin (ie prosthetic joint infection) - Patients in terminal palliation, where death is expected within 7 days. - Where the treating physician believes cloxacillin is not a first-line treatment. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: Aged ≥18 with penicillin susceptible S. aureus bacteraemia (PSSA), and able to provide written informed consent. Exclusion Criteria: * allergy to penicillin, * inability to give informed consent, * concomitant growth of other clinically significant bacteria in blood cultures * neutropenia -≥ 96h with prior antibiotics * When the per oral follow up medication can not be flukloxacillin or penicillinV/Amoxicillin (ie prosthetic joint infection) * Patients in terminal palliation, where death is expected within 7 days. * Where the treating physician believes cloxacillin is not a first-line treatment.

Treatments Being Tested

DRUG

Penicillin G_1200mg

benzylpenicillin preferred dosing 1gx4

DRUG

cloxacillin

cloxacillin 2gx4

Locations (1)

Skånes universitetssjukhus, Region Skåne
Lund, Sweden